Ugenesis Health Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 4 Year, 26 Days
- Last Filing with ROC 31 Mar 2024
About Ugenesis Health Science
Ugenesis Health Science Private Limited (UHSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 12 January 2021 (Four years 26 days old ). Its registered office is in Amravati, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Arundhati Utane, Bhavna Utane, and Rajesh Utane serve as directors at the Company.
Company Details
-
Location
Amravati, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85190MH2021PTC353372
-
Company No.
353372
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Jan 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Ugenesis Health Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arundhati Utane
|
Director | 12-Jan-2021 | Current |
|
Bhavna Utane
|
Director | 12-Jan-2021 | Current |
|
Rajesh Utane
|
Director | 12-Jan-2021 | Current |
Financial Performance of Ugenesis Health Science.
Ugenesis Health Science Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ugenesis Health Science?
Unlock access to Ugenesis Health Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Immaculate One LlpArundhati Utane is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ugenesis Health Science?
Ugenesis Health Science has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ugenesis Health Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ugenesis Health Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.